Evaluation of results after 112 radioembolizations with 90Y-microspheres

Autor: Casáns-Tormo, I., Guijarro-Rosaleny, J., Lluch-García, P., Rodríguez-Parra, H., Roselló-Keränen, S., Asensio-Valero, L.

Publikováno v: In Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) July-August 2023 42(4):255-264

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma.

Autor: Verlingue L; Gustave Roussy Institute of Oncology, Villejuif, France., Italiano A; Institut Bergonié Cancer Center, Bordeaux, France., Prenen H; Antwerp University Hospital, Edegem, Belgium., Guerra Alia EM; Ramón y Cajal University Hospital, Madrid, Spain., Tosi D; Montpellier Cancer Institute, Montpellier, France., Perets R; Division of Oncology, Clinical Research Institute at Rambam, Rambam Medical Center, Haifa, Israel., Lugowska I; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Moiseyenko V; Clinical Scientific and Practical Center, Saint-Petersburg, Russia., Gumus M; Istanbul Medeniyet University, Istanbul, Turkey., Arslan C; Izmir Economy University Medical Point Hospital, Izmir, Turkey., Lindsay CR; The Christie NHS Foundation Trust, Manchester, UK., Deva S; Auckland City Hospital, Auckland, New Zealand., Taus Á; Medical Oncology Department Hospital del Mar, CIBERONC, Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Rottey S; Gent University Hospital, Gent, Belgium., Cicin I; Trakya University, Edirne, Turkey., Goksu SS; Akdeniz University, Antalya, Turkey., Smolin A; Burdenko Main Military Hospital, Moscow, Russia., Roselló-Keränen S; INCLIVA Biomedical Research Institute, Hospital Clinico Universitario de Valencia, Valencia, Spain., Habigt C; Roche Pharma Research and Early Development, Penzburg, Germany., Marbach D; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Boetsch C; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Dejardin D; Roche Product Development, Data Science, Roche Innovation Center, Basel, Switzerland., Sleiman N; Roche Product Development, Data Science, Roche Innovation Center, Basel, Switzerland., Evers S; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Richard M; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Ardeshir C; Roche Products Ltd, Welwyn Garden City, UK., Charo J; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Kraxner A; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Teichgräber V; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Keshelava N; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Dziadziuszko R; Medical University of Gdansk, Gdansk, Poland. Electronic address: rafal.dziadziuszko@gumed.edu.pl.

Publikováno v: EBioMedicine [EBioMedicine] 2024 Nov; Vol. 109, pp. 105374. Date of Electronic Publication: 2024 Oct 11.

Does month of birth influence colorectal cancer prognosis?

Autor: Martín-Arévalo J; Colorectal Surgery Unit, Department of General and Digestive Surgery, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Av. Blasco Ibáñez, 17, 46010, Valencia, Spain.; Department of Surgery, University of Valencia, Valencia, Spain., Moro-Valdezate D; Colorectal Surgery Unit, Department of General and Digestive Surgery, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Av. Blasco Ibáñez, 17, 46010, Valencia, Spain. david.moro@uv.es.; Department of Surgery, University of Valencia, Valencia, Spain. david.moro@uv.es., Pla-Martí V; Colorectal Surgery Unit, Department of General and Digestive Surgery, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Av. Blasco Ibáñez, 17, 46010, Valencia, Spain.; Department of Surgery, University of Valencia, Valencia, Spain., García-Botello S; Colorectal Surgery Unit, Department of General and Digestive Surgery, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Av. Blasco Ibáñez, 17, 46010, Valencia, Spain.; Department of Surgery, University of Valencia, Valencia, Spain., Moya-Marcos P; Department of Surgery, University of Valencia, Valencia, Spain., Izquierdo-Moreno A; Colorectal Surgery Unit, Department of General and Digestive Surgery, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Av. Blasco Ibáñez, 17, 46010, Valencia, Spain., Pérez-Santiago L; Colorectal Surgery Unit, Department of General and Digestive Surgery, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Av. Blasco Ibáñez, 17, 46010, Valencia, Spain., Casado-Rodrigo D; Colorectal Surgery Unit, Department of General and Digestive Surgery, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Av. Blasco Ibáñez, 17, 46010, Valencia, Spain., Roselló-Keränen S; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, Valencia, Spain., Espí-Macías A; Colorectal Surgery Unit, Department of General and Digestive Surgery, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Av. Blasco Ibáñez, 17, 46010, Valencia, Spain.; Department of Surgery, University of Valencia, Valencia, Spain.

Publikováno v: Langenbeck's archives of surgery [Langenbecks Arch Surg] 2023 Oct 26; Vol. 408 (1), pp. 419. Date of Electronic Publication: 2023 Oct 26.

360P Epigenetic engineering on CDX2 allows to determine the interplaying consequences with other genetic and transcriptomic events in colorectal cancer

Autor: Gimeno-Valiente, F., Duréndez, E., Badía, J., Martínez-Ciarpaglini, C., Iglesias, M., Linares, J.L., Huerta, M., Moro, D., Gambardella, V., Martín-Arana, J., Fleitas, T.C., Roselló Keränen, S., Cabeza Segura, M., García-Mico, B., Rentero-Garrido, P., Roda, D., Castillo, J., Cervantes, A., Calon, A., Tarazona Llavero, N.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S700-S700

Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients

Autor: Martín Martorell P, Huerta M, Compañ Quilis A, Abellán R, Seda E, Blesa S, Chaves FJ, Dualde Beltrán D, Roselló Keränen S, Franco J, Insa A

Publikováno v: Clinical Lung Cancer
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::986d72a76bb6627e319b5b03ff1891c3
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1878